Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integer HoldingsITGR +1.15%83 Receivables Turnover is 1.30 as of Mar. 2026. GuruFocus rates ITGR with a GF Score™ of 83/100 and a GF Value™ of $117.21 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 812 Medical Devices & Instruments companies, Integer Holdings ranks better than 55.67% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Integer Holdings's Revenue for the
three
months ended in Mar. 2026 was $440 Mil. Integer Holdings's average Accounts Receivable for the
three
months ended in Mar. 2026 was $337 Mil.
Hence, Integer Holdings's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.30.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Integer Holdings Receivables Turnover Related Terms
Integer Holdings Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Integer Holdings's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ITGR vs HAE, ESTA, IRTC: Receivables Turnover Comparison
For the Medical Devices subindustry, Integer Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integer Holdings Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Integer Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integer Holdings (ITGR) has a Receivables Turnover of 1.30 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Integer Holdings and its competitors. According to the industry distribution chart, Integer Holdings ranks #360 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 44.3%.
Is Integer Holdings' Receivables Turnover too high?
Integer Holdings' current Receivables Turnover is 1.30. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Integer Holdings' value of 1.30 is 76.4% below this industry median. Based on the distribution chart, Integer Holdings ranks #360 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Integer Holdings has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integer Holdings' Receivables Turnover compare to HAE and ESTA?
According to the Medical Devices & Instruments industry distribution chart, Integer Holdings ranks #360 out of 812 companies for Receivables Turnover. This puts Integer Holdings in the upper half of its industry. The industry median Receivables Turnover is 5.51. Integer Holdings' value of 1.30 is 76.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integer Holdings's current Receivables Turnover of 1.30 is 76.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Integer Holdings and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integer Holdings's current Receivables Turnover is 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integer Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integer Holdings (ITGR) is currently considered Modestly Undervalued. The stock's GF Value™ is $117.21, compared to a current price of $98.62 — trading 15.9% below its estimated fair value. The current Receivables Turnover is 1.30 and 76.4% below the Medical Devices & Instruments industry median of 5.51. Integer Holdings' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Integer Holdings (ITGR), the current Receivables Turnover is 1.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integer Holdings (ITGR) Overvalued in 2026?
Based on GuruFocus' analysis, Integer Holdings stock appears to be undervalued.
The current stock price of $98.62 is trading 15.9% below its estimated GF Value™ of $117.21.
GuruFocus considers Integer Holdings to be Modestly Undervalued.
Key valuation signals for ITGR:
Receivables Turnover: 1.30
GF Value™: $117.21 vs. price of $98.62 (15.9% below fair value)
Industry Position: 76.4% below the Medical Devices & Instruments median (#360 of 812)
No single metric tells the full story. See the ITGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
83GF Score
Get the complete analysis for ITGR
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ITGR has been successfully added to your 
